Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration
- Status
- UNKNOWN
- Phase
- PHASE3
Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intravitreal Bevacizumab for Diabetic Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2